Cambridge Investment Research Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-101,326
| Closed | -$90K | – | 3302 |
|
|
2022
Q4 | $90K | Buy |
101,326
+1,273
| +1% | +$1.13K | ﹤0.01% | 2930 |
|
|
2022
Q3 | $157K | Buy |
100,053
+10,095
| +11% | +$15.8K | ﹤0.01% | 2771 |
|
|
2022
Q2 | $181K | Buy |
89,958
+2,556
| +3% | +$5.14K | ﹤0.01% | 2747 |
|
|
2022
Q1 | $204K | Buy |
87,402
+23,706
| +37% | +$55.3K | ﹤0.01% | 2856 |
|
|
2021
Q4 | $296K | Sell |
63,696
-20,648
| -24% | -$96K | ﹤0.01% | 2538 |
|
|
2021
Q3 | $644K | Sell |
84,344
-932
| -1% | -$7.12K | ﹤0.01% | 1849 |
|
|
2021
Q2 | $826K | Sell |
85,276
-2,750
| -3% | -$26.6K | ﹤0.01% | 1678 |
|
|
2021
Q1 | $728K | Sell |
88,026
-6,806
| -7% | -$56.3K | ﹤0.01% | 1642 |
|
|
2020
Q4 | $647K | Buy |
94,832
+36,326
| +62% | +$248K | ﹤0.01% | 1597 |
|
|
2020
Q3 | $652K | Buy |
58,506
+15,491
| +36% | +$173K | ﹤0.01% | 1436 |
|
|
2020
Q2 | $270K | Buy |
+43,015
| New | +$270K | ﹤0.01% | 1961 |
|